Healthcare Sector Stocks
The Healthcare sector has a total of 1051 stocks, with a combined market cap of $8.98 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 44.69.
Market Cap
8.98T
Revenue
4.59T
Profits
200.9B
PE Ratio
44.69
Profit Margin
4.38%
Dividend Yield
0.40%
1052 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.06T | 1.97% | 1,909,944 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 624.12B | 1.42% | 8,063,250 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 453.92B | 1.43% | 4,623,011 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 384.65B | -1.80% | 4,868,746 | 450.13B |
| 5 | MRK | Merck & Co., Inc. | 322.26B | 2.36% | 8,531,273 | 65.77B |
| 6 | NVS | Novartis AG | 296.98B | 2.00% | 2,105,476 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 261.88B | -0.86% | 2,394,069 | 60.44B |
| 8 | NVO | Novo Nordisk A/S | 215.49B | -0.02% | 8,178,175 | 50.57B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 212.69B | 8.71% | 5,806,158 | 46.34B |
| 10 | AMGN | Amgen Inc. | 200.50B | 1.49% | 2,931,906 | 37.22B |
| 11 | ABT | Abbott Laboratories | 175.49B | 0.18% | 9,959,504 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 162.47B | 0.40% | 6,299,287 | 29.74B |
| 13 | PFE | Pfizer Inc. | 142.54B | 0.77% | 30,876,684 | 63.32B |
| 14 | CVS | CVS Health Corporation | 136.38B | -0.49% | 5,823,895 | 405.62B |
| 15 | DHR | Danaher Corporation | 135.32B | 7.46% | 11,552,905 | 25.11B |
| 16 | BMY | Bristol-Myers Squibb Company | 125.61B | 1.23% | 7,621,785 | 48.48B |
| 17 | SYK | Stryker Corporation | 122.28B | 3.15% | 2,509,108 | 25.27B |
| 18 | VRTX | Vertex Pharmaceuticals Incorporated | 120.07B | 0.11% | 1,306,126 | 12.22B |
| 19 | ISRG | Intuitive Surgical, Inc. | 117.30B | -2.54% | 4,892,561 | 11.03B |
| 20 | MDT | Medtronic plc | 104.98B | 0.15% | 5,543,916 | 36.36B |
| 21 | SNY | Sanofi | 104.37B | -0.98% | 1,912,713 | 54.60B |
| 22 | GSK | GSK plc | 100.99B | -0.04% | 4,120,568 | 43.29B |
| 23 | MCK | McKesson Corporation | 96.53B | 1.28% | 755,412 | 403.43B |
| 24 | HCA | HCA Healthcare, Inc. | 83.52B | 1.25% | 1,481,609 | 76.39B |
| 25 | ELV | Elevance Health, Inc. | 82.26B | -2.51% | 1,134,233 | 201.11B |
| 26 | CI | The Cigna Group | 75.73B | 0.51% | 1,039,791 | 277.89B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 66.32B | 0.11% | 1,129,411 | 14.92B |
| 28 | BSX | Boston Scientific Corporation | 64.78B | 1.42% | 16,535,740 | 20.61B |
| 29 | COR | Cencora, Inc. | 59.35B | 1.49% | 1,166,312 | 328.68B |
| 30 | ARGX | argenx SE | 56.67B | 8.56% | 607,965 | 5.32B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 55.03B | -0.30% | 3,511,438 | 28.34B |
| 32 | CAH | Cardinal Health, Inc. | 52.93B | 2.47% | 1,837,736 | 250.74B |
| 33 | MDLN | Medline Inc. | 49.43B | 1.21% | 4,739,652 | 29.14B |
| 34 | EW | Edwards Lifesciences Corporation | 48.26B | -0.65% | 6,913,372 | 6.51B |
| 35 | HUM | Humana Inc. | 47.36B | -0.78% | 1,182,719 | 137.20B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 42.55B | -1.03% | 459,357 | 4.45B |
| 37 | HLN | Haleon plc | 42.39B | -1.42% | 9,034,543 | 14.85B |
| 38 | BDX | Becton, Dickinson and Company | 42.15B | -0.12% | 1,607,956 | 22.23B |
| 39 | RVMD | Revolution Medicines, Inc. | 40.13B | 3.13% | 2,283,154 | - |
| 40 | A | Agilent Technologies, Inc. | 39.47B | 4.71% | 2,935,857 | 7.23B |
| 41 | NTRA | Natera, Inc. | 37.91B | 0.18% | 598,334 | 2.50B |
| 42 | WAT | Waters Corporation | 37.55B | 3.13% | 1,458,705 | 3.77B |
| 43 | ONC | BeOne Medicines AG | 36.33B | 2.14% | 546,440 | 5.74B |
| 44 | TEVA | Teva Pharmaceutical Industries Limited | 36.31B | 3.42% | 4,451,648 | 17.35B |
| 45 | ALNY | Alnylam Pharmaceuticals, Inc. | 35.88B | 0.66% | 1,140,798 | 4.29B |
| 46 | IQV | IQVIA Holdings Inc. | 34.60B | 4.43% | 1,351,961 | 16.63B |
| 47 | RPRX | Royalty Pharma plc | 33.99B | 0.51% | 2,159,892 | 2.44B |
| 48 | ALC | Alcon Inc. | 32.65B | -0.21% | 1,349,091 | 10.63B |
| 49 | CNC | Centene Corporation | 31.47B | -3.26% | 4,751,801 | 178.33B |
| 50 | ZTS | Zoetis Inc. | 31.26B | 0.51% | 6,320,018 | 9.53B |
| 51 | ILMN | Illumina, Inc. | 29.78B | 3.14% | 1,220,931 | 4.39B |
| 52 | BIIB | Biogen Inc. | 29.62B | 1.46% | 1,032,070 | 9.94B |
| 53 | VEEV | Veeva Systems Inc. | 29.17B | -2.69% | 1,037,452 | 3.32B |
| 54 | GEHC | GE HealthCare Technologies Inc. | 28.20B | 0.94% | 4,471,136 | 20.98B |
| 55 | RMD | ResMed Inc. | 27.68B | -0.53% | 1,012,467 | 5.54B |
| 56 | DXCM | DexCom, Inc. | 27.20B | -1.33% | 3,264,982 | 4.82B |
| 57 | MTD | Mettler-Toledo International Inc. | 26.91B | 3.57% | 318,394 | 4.09B |
| 58 | PHG | Koninklijke Philips N.V. | 25.39B | -0.91% | 923,921 | 20.34B |
| 59 | ROIV | Roivant Sciences Ltd. | 25.25B | 0.54% | 4,246,756 | 8.26M |
| 60 | DGX | Quest Diagnostics Incorporated | 25.15B | 8.61% | 3,758,555 | 11.56B |
| 61 | WST | West Pharmaceutical Services, Inc. | 25.11B | -0.82% | 1,798,373 | 3.33B |
| 62 | LH | Labcorp Holdings Inc. | 23.86B | 3.40% | 1,506,097 | 14.14B |
| 63 | INCY | Incyte Corporation | 23.31B | 0.78% | 956,259 | 5.36B |
| 64 | INSM | Insmed Incorporated | 23.28B | 0.72% | 1,752,962 | 819.56M |
| 65 | BNTX | BioNTech SE | 23.28B | 0.25% | 539,216 | 3.23B |
| 66 | MRNA | Moderna, Inc. | 22.62B | -1.81% | 4,695,588 | 2.23B |
| 67 | UTHR | United Therapeutics Corporation | 22.48B | 0.47% | 241,123 | 3.17B |
| 68 | STE | STERIS plc | 20.53B | 0.03% | 454,354 | 5.94B |
| 69 | VTRS | Viatris Inc. | 20.12B | 1.59% | 7,908,878 | 14.56B |
| 70 | GH | Guardant Health, Inc. | 19.92B | -0.36% | 1,113,200 | 1.08B |
| 71 | GMAB | Genmab A/S | 17.78B | 1.11% | 1,135,423 | 3.90B |
| 72 | NBIX | Neurocrine Biosciences, Inc. | 17.51B | 0.85% | 1,103,194 | 3.10B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 17.34B | 1.09% | 1,607,277 | 8.41B |
| 74 | THC | Tenet Healthcare Corporation | 17.14B | 1.88% | 1,774,471 | 22.64B |
| 75 | MEDP | Medpace Holdings, Inc. | 16.91B | 14.71% | 1,177,299 | 2.78B |
| 76 | ASND | Ascendis Pharma A/S | 16.66B | 0.29% | 308,315 | 998.25M |
| 77 | BBIO | BridgeBio Pharma, Inc. | 16.26B | 0.33% | 1,530,870 | 579.96M |
| 78 | JAZZ | Jazz Pharmaceuticals plc | 16.01B | 1.78% | 527,986 | 4.44B |
| 79 | DVA | DaVita Inc. | 15.04B | 0.94% | 480,446 | 13.84B |
| 80 | BTSG | BrightSpring Health Services, Inc. | 14.55B | 0.14% | 3,657,207 | 13.65B |
| 81 | EXEL | Exelixis, Inc. | 13.99B | 1.22% | 1,659,665 | 2.38B |
| 82 | COO | The Cooper Companies, Inc. | 13.70B | -0.38% | 2,048,710 | 4.23B |
| 83 | SOLV | Solventum Corporation | 13.38B | -0.52% | 723,872 | 8.26B |
| 84 | ICLR | ICON Public Limited Company | 13.05B | 1.82% | 1,281,986 | 8.27B |
| 85 | FMS | Fresenius Medical Care AG | 12.98B | 0.58% | 368,301 | 22.32B |
| 86 | RVTY | Revvity, Inc. | 12.63B | 2.38% | 1,495,343 | 2.90B |
| 87 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.53B | 1.06% | 160,514 | 1.13B |
| 88 | SNN | Smith & Nephew plc | 12.52B | -0.57% | 1,201,261 | 6.16B |
| 89 | PEN | Penumbra, Inc. | 12.50B | 0.44% | 690,850 | 1.45B |
| 90 | AXSM | Axsome Therapeutics, Inc. | 12.43B | 0.80% | 500,365 | 708.24M |
| 91 | ELAN | Elanco Animal Health Incorporated | 12.38B | -2.21% | 5,910,903 | 4.89B |
| 92 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.22B | -2.16% | 2,479,807 | 622.01M |
| 93 | ALGN | Align Technology, Inc. | 12.05B | -2.45% | 820,952 | 4.10B |
| 94 | SMMT | Summit Therapeutics Inc. | 11.63B | 1.63% | 3,283,514 | - |
| 95 | BMRN | BioMarin Pharmaceutical Inc. | 11.38B | 0.80% | 2,503,781 | 3.24B |
| 96 | ABVX | ABIVAX Société Anonyme | 11.22B | 1.10% | 750,456 | 5.67M |
| 97 | BAX | Baxter International Inc. | 11.19B | -0.32% | 4,516,814 | 11.32B |
| 98 | TECH | Bio-Techne Corporation | 11.18B | -0.01% | 3,113,180 | 1.21B |
| 99 | CYTK | Cytokinetics, Incorporated | 11.12B | -0.33% | 1,076,212 | 105.82M |
| 100 | CRL | Charles River Laboratories International, Inc. | 11.04B | 4.84% | 1,075,145 | 4.03B |
| 101 | EHC | Encompass Health Corporation | 11.02B | 0.04% | 423,427 | 6.07B |
| 102 | PODD | Insulet Corporation | 10.97B | -0.35% | 1,141,160 | 2.90B |
| 103 | MOH | Molina Healthcare, Inc. | 10.43B | -9.67% | 3,079,595 | 42.47B |
| 104 | CORT | Corcept Therapeutics Incorporated | 10.38B | 6.36% | 981,135 | 769.10M |
| 105 | GMED | Globus Medical, Inc. | 10.24B | -0.11% | 1,162,578 | 3.10B |
| 106 | APGE | Apogee Therapeutics, Inc. | 10.08B | 0.13% | 691,295 | - |
| 107 | RDY | Dr. Reddy's Laboratories Limited | 10.03B | 3.69% | 7,332,865 | 3.50B |
| 108 | ENSG | The Ensign Group, Inc. | 9.71B | -0.94% | 493,685 | 5.27B |
| 109 | KRYS | Krystal Biotech, Inc. | 9.65B | -2.76% | 4,669,814 | 417.30M |
| 110 | HSIC | Henry Schein, Inc. | 9.63B | -0.33% | 1,024,611 | 13.38B |
| 111 | HALO | Halozyme Therapeutics, Inc. | 9.59B | 3.88% | 1,751,413 | 1.51B |
| 112 | BRKR | Bruker Corporation | 9.46B | 4.03% | 1,689,026 | 3.46B |
| 113 | IONS | Ionis Pharmaceuticals, Inc. | 9.23B | 3.44% | 3,834,344 | 1.06B |
| 114 | UHS | Universal Health Services, Inc. | 9.16B | 1.29% | 885,867 | 17.76B |
| 115 | KYMR | Kymera Therapeutics, Inc. | 9.08B | 0.04% | 431,638 | 51.48M |
| 116 | PRAX | Praxis Precision Medicines, Inc. | 8.99B | 3.30% | 325,378 | 7.46M |
| 117 | GKOS | Glaukos Corporation | 8.93B | -0.48% | 420,733 | 551.35M |
| 118 | ALKS | Alkermes plc | 8.83B | 0.74% | 1,488,266 | 1.56B |
| 119 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.82B | -0.08% | 4,268,878 | 18.07M |
| 120 | SYRE | Spyre Therapeutics, Inc. | 8.79B | 0.83% | 635,067 | - |
| 121 | OSCR | Oscar Health, Inc. | 8.71B | -1.97% | 4,619,210 | 13.30B |
| 122 | PTGX | Protagonist Therapeutics, Inc. | 8.71B | -0.01% | 605,784 | 74.06M |
| 123 | QGEN | Qiagen N.V. | 8.57B | 2.17% | 2,725,564 | 2.10B |
| 124 | BIO | Bio-Rad Laboratories, Inc. | 8.47B | 3.41% | 352,751 | 2.59B |
| 125 | TEM | Tempus AI, Inc. | 8.28B | -2.02% | 4,474,659 | 1.36B |
| 126 | ATR | AptarGroup, Inc. | 8.23B | -0.13% | 382,934 | 3.87B |
| 127 | IMVT | Immunovant, Inc. | 8.08B | 0.82% | 784,113 | - |
| 128 | PCVX | Vaxcyte, Inc. | 8.03B | -0.64% | 750,404 | - |
| 129 | LQDA | Liquidia Corporation | 7.92B | 2.29% | 1,586,856 | 288.07M |
| 130 | HQY | HealthEquity, Inc. | 7.89B | -1.69% | 713,798 | 1.34B |
| 131 | TGTX | TG Therapeutics, Inc. | 7.87B | 5.35% | 2,961,244 | 700.35M |
| 132 | RGEN | Repligen Corporation | 7.76B | -1.78% | 2,793,139 | 763.34M |
| 133 | IBRX | ImmunityBio, Inc. | 7.75B | -1.46% | 6,132,648 | 140.98M |
| 134 | AVTR | Avantor, Inc. | 7.75B | 3.65% | 15,496,603 | 6.55B |
| 135 | HIMS | Hims & Hers Health, Inc. | 7.58B | 3.35% | 32,621,683 | 2.37B |
| 136 | PACS | PACS Group, Inc. | 7.09B | -0.53% | 568,393 | 5.43B |
| 137 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.04B | -1.26% | 470,591 | 217.17M |
| 138 | MIRM | Mirum Pharmaceuticals, Inc. | 6.97B | -0.10% | 1,403,721 | 569.61M |
| 139 | COGT | Cogent Biosciences, Inc. | 6.88B | 1.77% | 3,181,310 | - |
| 140 | LNTH | Lantheus Holdings, Inc. | 6.75B | -0.84% | 641,105 | 1.55B |
| 141 | ERAS | Erasca, Inc. | 6.71B | -0.87% | 3,883,088 | - |
| 142 | CHE | Chemed Corporation | 6.65B | -0.10% | 110,808 | 2.54B |
| 143 | PTCT | PTC Therapeutics, Inc. | 6.51B | 0.06% | 759,374 | 827.11M |
| 144 | GRFS | Grifols, S.A. | 6.46B | -4.31% | 397,792 | 8.58B |
| 145 | XENE | Xenon Pharmaceuticals Inc. | 6.32B | -1.15% | 490,796 | 7.50M |
| 146 | CGON | CG Oncology, Inc. | 6.27B | 2.61% | 1,036,507 | 5.07M |
| 147 | BLTE | Belite Bio, Inc | 6.15B | -0.55% | 154,103 | - |
| 148 | TXG | 10x Genomics, Inc. | 6.10B | 2.15% | 2,985,306 | 638.78M |
| 149 | LGND | Ligand Pharmaceuticals Incorporated | 5.99B | -0.69% | 355,489 | 274.48M |
| 150 | HNGE | Hinge Health, Inc. | 5.93B | -3.02% | 1,299,854 | 646.34M |
| 151 | BLLN | BillionToOne, Inc. | 5.93B | -0.23% | 463,115 | 354.54M |
| 152 | SRRK | Scholar Rock Holding Corporation | 5.93B | 2.44% | 1,028,993 | - |
| 153 | TFX | Teleflex Incorporated | 5.81B | -2.70% | 418,305 | 2.13B |
| 154 | TWST | Twist Bioscience Corporation | 5.76B | -1.88% | 1,211,472 | 409.48M |
| 155 | AMRX | Amneal Pharmaceuticals, Inc. | 5.73B | 1.24% | 2,423,822 | 3.05B |
| 156 | DNTH | Dianthus Therapeutics, Inc. | 5.73B | 1.98% | 884,008 | 1.34M |
| 157 | DFTX | Definium Therapeutics, Inc. | 5.70B | -1.69% | 775,167 | - |
| 158 | BLCO | Bausch + Lomb Corporation | 5.70B | 0.19% | 409,791 | 5.21B |
| 159 | ORKA | Oruka Therapeutics, Inc. | 5.55B | -0.63% | 615,947 | - |
| 160 | STVN | Stevanato Group S.p.A. | 5.30B | 0.15% | 291,132 | 1.39B |
| 161 | TVTX | Travere Therapeutics, Inc. | 5.27B | 0.75% | 1,569,225 | 536.20M |
| 162 | SHC | Sotera Health Company | 4.99B | 1.16% | 5,700,375 | 1.19B |
| 163 | INDV | Indivior Pharmaceuticals, Inc. | 4.94B | 0.15% | 2,386,619 | 1.29B |
| 164 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.85B | 0.98% | 321,684 | 754.05M |
| 165 | MANE | Veradermics, Incorporated | 4.84B | 5.47% | 394,144 | - |
| 166 | RDNT | RadNet, Inc. | 4.80B | 2.97% | 459,091 | 2.14B |
| 167 | CRSP | CRISPR Therapeutics AG | 4.68B | 0.61% | 1,713,250 | 4.10M |
| 168 | VCYT | Veracyte, Inc. | 4.62B | -0.22% | 615,700 | 541.74M |
| 169 | MMED | MiniMed Group, Inc. | 4.59B | - | 749,865 | 3.10B |
| 170 | LEGN | Legend Biotech Corporation | 4.55B | - | 943,631 | 1.14B |
| 171 | CAI | Caris Life Sciences, Inc. | 4.42B | 1.76% | 2,540,923 | 907.29M |
| 172 | MMSI | Merit Medical Systems, Inc. | 4.36B | - | 444,809 | 1.54B |
| 173 | LIVN | LivaNova PLC | 4.32B | 0.43% | 707,177 | 1.43B |
| 174 | CELC | Celcuity Inc. | 4.31B | -2.00% | 1,751,907 | - |
| 175 | NVST | Envista Holdings Corporation | 4.26B | -0.98% | 2,739,627 | 2.81B |
| 176 | ACAD | ACADIA Pharmaceuticals Inc. | 4.25B | -0.52% | 1,272,019 | 1.10B |
| 177 | EWTX | Edgewise Therapeutics, Inc. | 4.23B | 2.50% | 955,980 | - |
| 178 | LFST | LifeStance Health Group, Inc. | 4.19B | -1.82% | 1,800,419 | 1.49B |
| 179 | PBLS | Parabilis Medicines, Inc. | 4.18B | 6.49% | 518,185 | - |
| 180 | RLAY | Relay Therapeutics, Inc. | 4.16B | -0.93% | 1,241,745 | 10.68M |
| 181 | WAY | Waystar Holding Corp. | 4.14B | 3.80% | 2,845,859 | 1.16B |
| 182 | ALHC | Alignment Healthcare, Inc. | 4.13B | -3.71% | 3,263,621 | 4.26B |
| 183 | VKTX | Viking Therapeutics, Inc. | 4.11B | -5.15% | 3,246,307 | - |
| 184 | CON | Concentra Group Holdings Parent, Inc. | 4.03B | 0.83% | 690,571 | 2.23B |
| 185 | TNGX | Tango Therapeutics, Inc. | 3.97B | -2.31% | 1,357,147 | 56.99M |
| 186 | DYN | Dyne Therapeutics, Inc. | 3.95B | 2.93% | 4,670,894 | - |
| 187 | ICUI | ICU Medical, Inc. | 3.84B | -2.53% | 346,675 | 2.16B |
| 188 | RCUS | Arcus Biosciences, Inc. | 3.74B | -0.80% | 1,217,571 | 236.00M |
| 189 | DNLI | Denali Therapeutics Inc. | 3.72B | -0.93% | 1,113,040 | - |
| 190 | ELVN | Enliven Therapeutics, Inc. | 3.69B | -0.08% | 656,028 | - |
| 191 | DOCS | Doximity, Inc. | 3.68B | -0.20% | 2,110,508 | 644.86M |
| 192 | GPCR | Structure Therapeutics Inc. | 3.61B | 0.77% | 665,366 | - |
| 193 | ALMS | Alumis Inc. | 3.61B | -1.77% | 649,987 | 8.40M |
| 194 | NAMS | NewAmsterdam Pharma Company N.V. | 3.57B | -3.63% | 872,308 | 22.57M |
| 195 | ADPT | Adaptive Biotechnologies Corporation | 3.57B | 1.64% | 2,763,907 | 295.41M |
| 196 | OGN | Organon & Co. | 3.56B | 0.30% | 6,563,597 | 6.16B |
| 197 | IRTC | iRhythm Holdings, Inc. | 3.54B | 1.51% | 383,691 | 787.85M |
| 198 | HAE | Haemonetics Corporation | 3.52B | -0.81% | 598,288 | 1.33B |
| 199 | TLX | Telix Pharmaceuticals Limited | 3.47B | 1.84% | 121,276 | 803.79M |
| 200 | BKD | Brookdale Senior Living Inc. | 3.46B | -1.02% | 3,671,303 | 3.00B |
| 201 | NHC | National HealthCare Corporation | 3.46B | 0.53% | 123,276 | 1.53B |
| 202 | IDYA | IDEAYA Biosciences, Inc. | 3.44B | 3.51% | 847,693 | 225.27M |
| 203 | ARQT | Arcutis Biotherapeutics, Inc. | 3.42B | -2.04% | 1,031,413 | 415.62M |
| 204 | ITGR | Integer Holdings Corporation | 3.31B | 0.97% | 400,484 | 1.86B |
| 205 | OPCH | Option Care Health, Inc. | 3.31B | -0.33% | 1,900,154 | 5.67B |
| 206 | PRVA | Privia Health Group, Inc. | 3.15B | -1.58% | 1,218,447 | 2.25B |
| 207 | ACHC | Acadia Healthcare Company, Inc. | 3.13B | -2.21% | 1,987,936 | 3.37B |
| 208 | MBX | MBX Biosciences, Inc. | 3.03B | 9.04% | 537,812 | - |
| 209 | GRAL | GRAIL, Inc. | 3.02B | -0.42% | 647,287 | 156.12M |
| 210 | WRBY | Warby Parker Inc. | 2.98B | -0.98% | 2,500,735 | 890.57M |
| 211 | IRON | Disc Medicine, Inc. | 2.90B | 2.07% | 273,756 | - |
| 212 | RGC | Regencell Bioscience Holdings Limited | 2.78B | -6.02% | 156,746 | - |
| 213 | CLDX | Celldex Therapeutics, Inc. | 2.78B | 1.87% | 856,469 | 865.00K |
| 214 | SUPN | Supernus Pharmaceuticals, Inc. | 2.74B | 0.53% | 463,337 | 776.83M |
| 215 | QURE | uniQure N.V. | 2.71B | -2.35% | 837,063 | 18.09M |
| 216 | ESTA | Establishment Labs Holdings Inc. | 2.68B | -2.95% | 549,017 | 229.58M |
| 217 | RARE | Ultragenyx Pharmaceutical Inc. | 2.65B | -2.28% | 1,888,467 | 670.00M |
| 218 | ATAI | AtaiBeckley Inc. | 2.65B | -0.14% | 9,045,320 | 3.49M |
| 219 | VERA | Vera Therapeutics, Inc. | 2.61B | 0.80% | 2,972,219 | - |
| 220 | BEAM | Beam Therapeutics Inc. | 2.58B | -2.74% | 2,957,728 | 164.01M |
| 221 | KOD | Kodiak Sciences Inc. | 2.56B | -2.15% | 387,196 | - |
| 222 | XRAY | DENTSPLY SIRONA Inc. | 2.55B | -4.14% | 7,748,865 | 3.68B |
| 223 | TARS | Tarsus Pharmaceuticals, Inc. | 2.52B | 1.74% | 1,088,820 | 535.08M |
| 224 | GRDN | Guardian Pharmacy Services, Inc. | 2.50B | -0.83% | 768,311 | 1.46B |
| 225 | IMNM | Immunome, Inc. | 2.49B | -3.80% | 1,300,140 | 4.02M |
| 226 | NRIX | Nurix Therapeutics, Inc. | 2.46B | 0.59% | 965,874 | 36.77M |
| 227 | TMDX | TransMedics Group, Inc. | 2.46B | -0.10% | 600,940 | 635.89M |
| 228 | TRVI | Trevi Therapeutics, Inc. | 2.44B | -1.04% | 2,375,413 | - |
| 229 | SLS | SELLAS Life Sciences Group, Inc. | 2.43B | 2.15% | 5,571,900 | - |
| 230 | PGNY | Progyny, Inc. | 2.40B | -2.07% | 747,148 | 1.29B |
| 231 | CLOV | Clover Health Investments, Corp. | 2.40B | -2.57% | 3,580,907 | 2.21B |
| 232 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.38B | -1.37% | 1,635,328 | 885.72M |
| 233 | MLYS | Mineralys Therapeutics, Inc. | 2.38B | -0.04% | 853,556 | - |
| 234 | NKTR | Nektar Therapeutics | 2.34B | 0.06% | 631,124 | 55.63M |
| 235 | NVCR | NovoCure Limited | 2.33B | 28.39% | 8,948,690 | 699.19M |
| 236 | PHVS | Pharvaris N.V. | 2.32B | -3.20% | 366,233 | - |
| 237 | PBH | Prestige Consumer Healthcare Inc. | 2.32B | -0.16% | 542,936 | 1.09B |
| 238 | VCEL | Vericel Corporation | 2.30B | 1.09% | 715,028 | 292.09M |
| 239 | IOVA | Iovance Biotherapeutics, Inc. | 2.29B | -0.77% | 9,732,094 | 285.61M |
| 240 | NUVB | Nuvation Bio Inc. | 2.26B | -0.92% | 4,261,712 | 143.05M |
| 241 | KLRA | Kailera Therapeutics, Inc. | 2.25B | -2.19% | 609,461 | - |
| 242 | LMAT | LeMaitre Vascular, Inc. | 2.23B | -1.34% | 286,642 | 256.28M |
| 243 | ZLAB | Zai Lab Limited | 2.21B | -4.00% | 660,434 | 453.28M |
| 244 | BHVN | Biohaven Ltd. | 2.21B | -0.68% | 1,549,227 | - |
| 245 | AGIO | Agios Pharmaceuticals, Inc. | 2.16B | 0.64% | 778,074 | 66.05M |
| 246 | PLSE | Pulse Biosciences, Inc. | 2.15B | -5.37% | 493,040 | 751.00K |
| 247 | COAG | Hemab Therapeutics Holdings, Inc. | 2.14B | -6.91% | 536,508 | - |
| 248 | VRDN | Viridian Therapeutics, Inc. | 2.13B | 0.47% | 1,346,735 | 70.92M |
| 249 | HTFL | HeartFlow, Inc. | 2.12B | 1.57% | 1,066,838 | 191.42M |
| 250 | AXGN | Axogen, Inc. | 2.11B | 0.91% | 851,402 | 238.11M |
| 251 | NEOG | Neogen Corporation | 2.09B | -2.24% | 1,515,045 | 870.56M |
| 252 | HRMY | Harmony Biosciences Holdings, Inc. | 2.07B | 2.70% | 782,631 | 899.11M |
| 253 | URGN | UroGen Pharma Ltd. | 2.07B | 1.05% | 494,668 | 140.49M |
| 254 | PVLA | Palvella Therapeutics, Inc. | 2.05B | 0.72% | 134,814 | - |
| 255 | MD | Pediatrix Medical Group, Inc. | 2.05B | -0.97% | 604,725 | 1.93B |
| 256 | ADUS | Addus HomeCare Corporation | 2.05B | 0.47% | 248,222 | 1.45B |
| 257 | MESO | Mesoblast Limited | 2.01B | -1.35% | 103,693 | 65.38M |
| 258 | NBTX | Nanobiotix S.A. | 2.00B | -2.06% | 153,060 | 38.27M |
| 259 | SION | Sionna Therapeutics, Inc. | 1.99B | -2.15% | 811,061 | - |
| 260 | RAPP | Rapport Therapeutics, Inc. | 1.98B | 0.12% | 228,619 | 20.00M |
| 261 | AVAH | Aveanna Healthcare Holdings Inc. | 1.98B | -3.71% | 2,094,933 | 2.52B |
| 262 | PGEN | Precigen, Inc. | 1.98B | 4.14% | 3,101,198 | 31.60M |
| 263 | SGRY | Surgery Partners, Inc. | 1.97B | 0.46% | 1,078,084 | 3.34B |
| 264 | HCM | HUTCHMED (China) Limited | 1.97B | -1.44% | 45,780 | 548.51M |
| 265 | AUPH | Aurinia Pharmaceuticals Inc. | 1.96B | -0.59% | 675,893 | 298.30M |
| 266 | ZBIO | Zenas BioPharma, Inc. | 1.96B | -1.59% | 402,041 | 10.00M |
| 267 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.96B | -0.62% | 816,143 | -665.00K |
| 268 | GLUE | Monte Rosa Therapeutics, Inc. | 1.95B | -3.19% | 673,127 | 42.95M |
| 269 | CDNA | CareDx, Inc. | 1.94B | -0.45% | 749,922 | 412.82M |
| 270 | ADMA | ADMA Biologics, Inc. | 1.94B | -0.12% | 2,617,492 | 509.86M |
| 271 | KARD | Kardigan, Inc. | 1.94B | -5.21% | 190,622 | - |
| 272 | GHRS | GH Research PLC | 1.90B | -3.32% | 143,842 | - |
| 273 | OCUL | Ocular Therapeutix, Inc. | 1.89B | 0.35% | 1,811,983 | 52.04M |
| 274 | WGS | GeneDx Holdings Corp. | 1.88B | 1.25% | 372,524 | 442.68M |
| 275 | SNDX | Syndax Pharmaceuticals, Inc. | 1.88B | -3.81% | 1,306,561 | 217.17M |
| 276 | SNDA | Sonida Senior Living, Inc. | 1.88B | 0.43% | 367,325 | 367.34M |
| 277 | TSHA | Taysha Gene Therapies, Inc. | 1.86B | 3.00% | 2,441,982 | 7.47M |
| 278 | LKFT | Lakefront Biotherapeutics NV | 1.86B | -2.29% | 141,538 | 1.20B |
| 279 | NEO | NeoGenomics, Inc. | 1.85B | 1.64% | 1,901,396 | 745.97M |
| 280 | STOK | Stoke Therapeutics, Inc. | 1.85B | 2.38% | 669,437 | 32.08M |
| 281 | ASTH | Astrana Health, Inc. | 1.85B | -2.27% | 872,194 | 3.53B |
| 282 | FTRE | Fortrea Holdings Inc. | 1.84B | 5.46% | 1,705,270 | 2.71B |
| 283 | TYRA | Tyra Biosciences, Inc. | 1.83B | 0.69% | 435,476 | - |
| 284 | UFPT | UFP Technologies, Inc. | 1.83B | -0.74% | 143,291 | 608.85M |
| 285 | BCAX | Bicara Therapeutics Inc. | 1.82B | -0.82% | 357,450 | - |
| 286 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.82B | -0.70% | 2,157,986 | 204.73M |
| 287 | OMCL | Omnicell, Inc. | 1.81B | -2.45% | 729,975 | 1.23B |
| 288 | IMCR | Immunocore Holdings plc | 1.81B | -0.08% | 550,176 | 412.81M |
| 289 | DMRA | Damora Therapeutics, Inc. | 1.80B | -2.73% | 488,960 | - |
| 290 | ALMR | Alamar Biosciences, Inc. | 1.79B | 3.07% | 135,478 | 87.16M |
| 291 | GENB | Generate Biomedicines, Inc. | 1.77B | -0.50% | 262,193 | 30.30M |
| 292 | AAPG | Ascentage Pharma Group International | 1.75B | 0.44% | 1,318 | 82.08M |
| 293 | BFLY | Butterfly Network, Inc. | 1.73B | 0.15% | 4,570,358 | 102.92M |
| 294 | ABCL | AbCellera Biologics Inc. | 1.73B | -1.05% | 2,892,320 | 79.21M |
| 295 | SRPT | Sarepta Therapeutics, Inc. | 1.68B | 0.38% | 2,485,535 | 2.18B |
| 296 | AGL | agilon health, inc. | 1.67B | -16.36% | 522,592 | 5.82B |
| 297 | ATRC | AtriCure, Inc. | 1.67B | -1.55% | 1,137,045 | 569.62M |
| 298 | ANIP | ANI Pharmaceuticals, Inc. | 1.67B | 1.19% | 245,695 | 923.71M |
| 299 | BHC | Bausch Health Companies Inc. | 1.66B | -2.41% | 1,383,546 | 10.53B |
| 300 | ZYME | Zymeworks Inc. | 1.66B | -1.03% | 357,873 | 81.26M |
| 301 | TRLV | Trulieve Cannabis Corp. | 1.64B | -1.38% | 508,304 | 1.17B |
| 302 | ANAB | AnaptysBio, Inc. | 1.63B | 4.37% | 674,422 | 232.39M |
| 303 | MLTX | MoonLake Immunotherapeutics | 1.60B | 2.22% | 743,202 | - |
| 304 | RXRX | Recursion Pharmaceuticals, Inc. | 1.60B | 1.01% | 18,832,247 | 66.41M |
| 305 | MPLT | MapLight Therapeutics, Inc. | 1.60B | -0.23% | 376,380 | - |
| 306 | CMPS | COMPASS Pathways plc | 1.58B | -1.84% | 1,822,118 | - |
| 307 | VIR | Vir Biotechnology, Inc. | 1.58B | -0.11% | 1,514,525 | 65.50M |
| 308 | INVA | Innoviva, Inc. | 1.56B | -1.07% | 942,291 | 420.69M |
| 309 | TDOC | Teladoc Health, Inc. | 1.56B | -2.91% | 5,131,118 | 2.51B |
| 310 | HROW | Harrow, Inc. | 1.56B | -2.22% | 366,233 | 268.68M |
| 311 | NTLA | Intellia Therapeutics, Inc. | 1.55B | -0.27% | 3,768,747 | 66.09M |
| 312 | HCSG | Healthcare Services Group, Inc. | 1.54B | -4.82% | 1,282,232 | 1.86B |
| 313 | MAZE | Maze Therapeutics, Inc. | 1.53B | -2.81% | 349,800 | 20.00M |
| 314 | XERS | Xeris Biopharma Holdings, Inc. | 1.52B | 0.36% | 2,191,195 | 314.85M |
| 315 | INNV | InnovAge Holding Corp. | 1.52B | -4.20% | 224,909 | 949.17M |
| 316 | SEPN | Septerna, Inc. | 1.51B | -2.13% | 298,231 | 72.26M |
| 317 | BLFS | BioLife Solutions, Inc. | 1.50B | -1.22% | 5,128,464 | 101.66M |
| 318 | ENOV | Enovis Corporation | 1.50B | -1.85% | 826,564 | 2.28B |
| 319 | ARDT | Ardent Health, Inc. | 1.49B | 0.48% | 392,855 | 6.43B |
| 320 | AVBP | ArriVent BioPharma, Inc. | 1.47B | 3.61% | 312,480 | - |
| 321 | INSP | Inspire Medical Systems, Inc. | 1.46B | 0.81% | 709,815 | 915.25M |
| 322 | FBRX | Forte Biosciences, Inc. | 1.46B | 5.42% | 752,163 | - |
| 323 | SVRA | Savara Inc. | 1.46B | 1.77% | 1,622,016 | - |
| 324 | XNCR | Xencor, Inc. | 1.45B | 0.10% | 832,625 | 97.36M |
| 325 | IART | Integra LifeSciences Holdings Corporation | 1.44B | -1.38% | 609,266 | 1.64B |
| 326 | PRGO | Perrigo Company plc | 1.40B | -3.53% | 3,013,557 | 4.18B |
| 327 | AHCO | AdaptHealth Corp. | 1.39B | -3.77% | 1,022,226 | 3.29B |
| 328 | PNTG | The Pennant Group, Inc. | 1.38B | -1.58% | 200,860 | 1.02B |
| 329 | PAHC | Phibro Animal Health Corporation | 1.38B | 0.68% | 162,048 | 1.50B |
| 330 | ABSI | Absci Corporation | 1.37B | -2.06% | 2,110,827 | 1.84M |
| 331 | AKTS | Aktis Oncology, Inc. | 1.33B | -3.22% | 298,722 | 8.28M |
| 332 | AVLN | Avalyn Pharma Inc. | 1.32B | 3.52% | 281,812 | - |
| 333 | TRAX | First Tracks Biotherapeutics, Inc. | 1.31B | -1.39% | 400,084 | - |
| 334 | AZTA | Azenta, Inc. | 1.30B | 4.20% | 607,300 | 596.48M |
| 335 | NVAX | Novavax, Inc. | 1.29B | -1.07% | 2,389,394 | 596.34M |
| 336 | AMN | AMN Healthcare Services, Inc. | 1.28B | -3.28% | 647,763 | 3.42B |
| 337 | PSNL | Personalis, Inc. | 1.28B | -2.00% | 3,745,715 | 64.52M |
| 338 | IMTX | Immatics N.V. | 1.27B | 1.31% | 352,460 | 43.00M |
| 339 | ARDX | Ardelyx, Inc. | 1.27B | 0.98% | 2,074,422 | 427.68M |
| 340 | KMTS | Kestra Medical Technologies, Ltd. | 1.26B | 3.26% | 214,166 | 95.13M |
| 341 | ATEC | Alphatec Holdings, Inc. | 1.26B | 1.86% | 1,335,844 | 787.08M |
| 342 | OMDA | Omada Health, Inc. | 1.26B | -2.93% | 1,901,277 | 283.30M |
| 343 | AHG | Akso Health Group | 1.26B | 2.08% | 7,848 | 13.83M |
| 344 | INBX | Inhibrx Biosciences, Inc. | 1.25B | -1.07% | 165,543 | 1.30M |
| 345 | CNMD | CONMED Corporation | 1.24B | -1.74% | 690,361 | 1.37B |
| 346 | AORT | Artivion, Inc. | 1.21B | -0.56% | 585,584 | 458.69M |
| 347 | ETON | Eton Pharmaceuticals, Inc. | 1.21B | 1.28% | 571,332 | 86.93M |
| 348 | STAA | STAAR Surgical Company | 1.20B | -2.10% | 460,190 | 290.38M |
| 349 | MNKD | MannKind Corporation | 1.20B | 1.30% | 2,941,996 | 360.78M |
| 350 | IRMD | IRADIMED CORPORATION | 1.20B | -0.23% | 82,772 | 86.28M |
| 351 | DRTS | Alpha Tau Medical Ltd. | 1.19B | 1.77% | 460,918 | - |
| 352 | SPTX | Seaport Therapeutics, Inc. | 1.17B | 3.00% | 90,640 | - |
| 353 | AVNS | Avanos Medical, Inc. | 1.17B | - | 748,686 | 715.90M |
| 354 | JBIO | Jade Biosciences, Inc. | 1.16B | -1.16% | 385,491 | - |
| 355 | TNDM | Tandem Diabetes Care, Inc. | 1.16B | -0.06% | 1,160,033 | 1.03B |
| 356 | COLL | Collegium Pharmaceutical, Inc. | 1.15B | 2.51% | 253,217 | 796.33M |
| 357 | CRVS | Corvus Pharmaceuticals, Inc. | 1.15B | -2.22% | 999,380 | - |
| 358 | CAPR | Capricor Therapeutics, Inc. | 1.15B | 4.87% | 2,009,541 | 11.13M |
| 359 | ALVO | Alvotech | 1.13B | -0.31% | 1,179,397 | 562.04M |
| 360 | QDEL | QuidelOrtho Corporation | 1.13B | -0.60% | 806,538 | 2.66B |
| 361 | SDGR | Schrödinger, Inc. | 1.13B | 0.67% | 716,739 | 254.91M |
| 362 | ORIC | ORIC Pharmaceuticals, Inc. | 1.13B | 1.30% | 2,168,817 | - |
| 363 | MGTX | MeiraGTx Holdings plc | 1.12B | -0.49% | 379,358 | 79.76M |
| 364 | WVE | Wave Life Sciences Ltd. | 1.11B | 0.70% | 2,223,140 | 71.80M |
| 365 | USPH | U.S. Physical Therapy, Inc. | 1.11B | -1.90% | 343,647 | 787.69M |
| 366 | CERT | Certara, Inc. | 1.11B | 3.19% | 3,347,859 | 419.75M |
| 367 | CGEM | Cullinan Therapeutics, Inc. | 1.06B | -2.10% | 368,588 | - |
| 368 | NUTX | Nutex Health Inc. | 1.06B | -2.32% | 96,853 | 879.95M |
| 369 | EYPT | EyePoint, Inc. | 1.05B | -1.50% | 1,284,724 | 7.61M |
| 370 | ANRO | Alto Neuroscience, Inc. | 1.04B | -1.40% | 257,880 | - |
| 371 | IVA | Inventiva S.A. | 1.04B | -0.66% | 636,793 | 7.94M |
| 372 | LMRI | Lumexa Imaging Holdings, Inc. | 1.03B | 0.94% | 296,014 | 1.03B |
| 373 | CRON | Cronos Group Inc. | 1.03B | -1.44% | 948,060 | 159.54M |
| 374 | VOR | Vor Biopharma Inc. | 1.03B | -2.72% | 553,285 | - |
| 375 | OLMA | Olema Pharmaceuticals, Inc. | 1.03B | 2.18% | 879,497 | - |
| 376 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.02B | 2.22% | 2,708,451 | 69.64M |
| 377 | PCRX | Pacira BioSciences, Inc. | 1.02B | 1.33% | 799,401 | 734.86M |
| 378 | PRCT | PROCEPT BioRobotics Corporation | 998.93M | -0.85% | 1,532,620 | 322.02M |
| 379 | LBRX | LB Pharmaceuticals Inc | 992.79M | -3.40% | 594,397 | - |
| 380 | GMRS | GMR Solutions Inc. | 983.05M | -1.17% | 353,805 | 5.83B |
| 381 | BIOA | BioAge Labs, Inc. | 973.51M | -0.18% | 416,642 | 10.32M |
| 382 | GDRX | GoodRx Holdings, Inc. | 972.00M | -2.05% | 678,179 | 787.89M |
| 383 | SANA | Sana Biotechnology, Inc. | 962.68M | 2.88% | 2,237,932 | - |
| 384 | BVS | Bioventus Inc. | 958.98M | -1.29% | 391,229 | 576.30M |
| 385 | JANX | Janux Therapeutics, Inc. | 958.67M | 0.64% | 931,839 | 13.73M |
| 386 | AVTX | Avalo Therapeutics, Inc. | 939.56M | -2.15% | 527,830 | 59.00K |
| 387 | GERN | Geron Corporation | 930.21M | 2.84% | 4,264,753 | 196.12M |
| 388 | KURA | Kura Oncology, Inc. | 927.69M | -0.85% | 727,767 | 71.64M |
| 389 | PHAT | Phathom Pharmaceuticals, Inc. | 921.39M | -0.85% | 733,229 | 204.89M |
| 390 | PHAR | Pharming Group N.V. | 891.75M | 1.62% | 2,227 | 369.49M |
| 391 | OPK | OPKO Health, Inc. | 883.46M | -0.85% | 2,958,377 | 581.12M |
| 392 | ABUS | Arbutus Biopharma Corporation | 882.99M | 3.23% | 1,475,495 | 191.45M |
| 393 | REPL | Replimune Group, Inc. | 878.07M | -2.70% | 3,792,174 | - |
| 394 | TBPH | Theravance Biopharma, Inc. | 873.82M | 0.30% | 939,155 | 109.78M |
| 395 | TALK | Talkspace, Inc. | 872.74M | - | 927,381 | 238.37M |
| 396 | ANNX | Annexon, Inc. | 868.37M | 1.34% | 2,194,269 | - |
| 397 | INMD | InMode Ltd. | 867.38M | -0.72% | 536,870 | 374.64M |
| 398 | GLAS | Glass House Brands Inc. | 854.16M | -4.65% | 450,734 | 177.68M |
| 399 | ODTX | Odyssey Therapeutics, Inc. | 846.00M | -5.05% | 150,685 | 1.06M |
| 400 | AMPH | Amphastar Pharmaceuticals, Inc. | 832.03M | -2.23% | 650,431 | 720.53M |
| 401 | DBVT | DBV Technologies S.A. | 798.75M | 1.69% | 101,689 | 5.04M |
| 402 | AVR | Anteris Technologies Global Corp. | 798.16M | -1.92% | 541,783 | 1.85M |
| 403 | AURA | Aura Biosciences, Inc. | 794.16M | 2.71% | 230,705 | - |
| 404 | SLDB | Solid Biosciences Inc. | 785.63M | -1.48% | 957,353 | - |
| 405 | CSTL | Castle Biosciences, Inc. | 772.81M | 2.70% | 407,874 | 339.92M |
| 406 | HSTM | HealthStream, Inc. | 770.99M | -1.86% | 234,271 | 311.78M |
| 407 | ACRS | Aclaris Therapeutics, Inc. | 765.36M | -2.49% | 879,818 | 8.37M |
| 408 | TENX | Tenax Therapeutics, Inc. | 747.98M | -1.01% | 1,400,925 | - |
| 409 | OMER | Omeros Corporation | 744.02M | 4.47% | 1,544,964 | 9.89M |
| 410 | ZVRA | Zevra Therapeutics, Inc. | 740.12M | 3.13% | 965,777 | 122.29M |
| 411 | CLYM | Climb Bio, Inc. | 730.64M | 1.43% | 573,619 | - |
| 412 | SIBN | SI-BONE, Inc. | 730.43M | -1.44% | 331,108 | 206.22M |
| 413 | DSGN | Design Therapeutics, Inc. | 726.37M | -1.27% | 403,095 | - |
| 414 | CTMX | CytomX Therapeutics, Inc. | 724.95M | - | 1,381,303 | 35.54M |
| 415 | CADL | Candel Therapeutics, Inc. | 722.44M | -2.28% | 766,393 | - |
| 416 | BBNX | Beta Bionics, Inc. | 718.78M | -1.10% | 1,329,100 | 110.24M |
| 417 | FTH | Faeth Therapeutics, Inc. | 715.62M | -3.14% | 100,733 | - |
| 418 | SSII | SS Innovations International, Inc. | 714.47M | -0.28% | 258,191 | 48.47M |
| 419 | NGNE | Neurogene Inc. | 708.80M | -1.50% | 155,578 | 925.00K |
| 420 | MNPR | Monopar Therapeutics Inc. | 708.06M | -6.03% | 298,103 | - |
| 421 | CBIO | Crescent Biopharma, Inc. | 703.75M | 7.58% | 348,056 | 11.88M |
| 422 | EVO | Evotec SE | 700.08M | 1.54% | 46,692 | 859.03M |
| 423 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 698.53M | -2.02% | 257,697 | - |
| 424 | SGP | SpyGlass Pharma, Inc. | 698.09M | 1.66% | 75,419 | - |
| 425 | DRUG | Bright Minds Biosciences Inc. | 695.36M | -5.53% | 248,033 | - |
| 426 | OCS | Oculis Holding AG | 690.84M | 0.09% | 240,336 | 1.40M |
| 427 | RIGL | Rigel Pharmaceuticals, Inc. | 681.25M | -2.59% | 383,199 | 299.77M |
| 428 | GYRE | Gyre Therapeutics, Inc. | 670.05M | 1.18% | 38,258 | 117.05M |
| 429 | BWAY | BrainsWay Ltd. | 654.34M | -0.30% | 201,569 | 56.22M |
| 430 | AGMB | AgomAb Therapeutics NV | 638.75M | 11.81% | 132,180 | - |
| 431 | NVCT | Nuvectis Pharma, Inc. | 635.24M | 4.46% | 325,762 | - |
| 432 | ACHV | Achieve Life Sciences, Inc. | 633.41M | -2.22% | 893,290 | - |
| 433 | RGNX | REGENXBIO Inc. | 632.45M | 0.49% | 1,364,649 | 87.82M |
| 434 | CRMD | CorMedix Inc. | 631.54M | 1.39% | 698,512 | 400.05M |
| 435 | ALLO | Allogene Therapeutics, Inc. | 628.18M | -2.15% | 5,640,285 | 22.00K |
| 436 | IMMX | Immix Biopharma, Inc. | 626.47M | -6.48% | 995,837 | - |
| 437 | IRWD | Ironwood Pharmaceuticals, Inc. | 623.88M | -2.32% | 1,075,280 | 361.51M |
| 438 | TCMD | Tactile Systems Technology, Inc. | 618.94M | -0.65% | 170,473 | 343.52M |
| 439 | CBLL | CeriBell, Inc. | 617.71M | -3.21% | 406,283 | 95.07M |
| 440 | MDXG | MiMedx Group, Inc. | 615.15M | -0.96% | 868,551 | 389.42M |
| 441 | PHR | Phreesia, Inc. | 605.76M | -2.10% | 677,980 | 495.59M |
| 442 | TECX | Tectonic Therapeutic, Inc. | 596.45M | 0.06% | 105,066 | - |
| 443 | SPRY | ARS Pharmaceuticals, Inc. | 595.82M | -0.99% | 2,660,291 | 98.99M |
| 444 | CTKB | Cytek Biosciences, Inc. | 588.89M | 0.44% | 766,518 | 204.17M |
| 445 | CERS | Cerus Corporation | 575.06M | -4.97% | 2,535,678 | 216.56M |
| 446 | FLGT | Fulgent Genetics, Inc. | 567.44M | 2.30% | 302,009 | 320.35M |
| 447 | ANGO | AngioDynamics, Inc. | 555.51M | -2.75% | 288,812 | 320.17M |
| 448 | RZLT | Rezolute, Inc. | 554.72M | 6.20% | 2,163,872 | - |
| 449 | ALT | Altimmune, Inc. | 552.31M | 1.07% | 1,625,861 | 36.00K |
| 450 | RLMD | Relmada Therapeutics, Inc. | 545.43M | 4.00% | 1,425,400 | - |
| 451 | STTK | Shattuck Labs, Inc. | 543.66M | 1.00% | 606,886 | 1.00M |
| 452 | VSTM | Verastem, Inc. | 543.06M | 4.92% | 2,193,681 | 49.59M |
| 453 | FDMT | 4D Molecular Therapeutics, Inc. | 542.63M | -5.29% | 567,285 | 88.24M |
| 454 | SLN | Silence Therapeutics plc | 540.83M | -3.21% | 480,128 | 839.00K |
| 455 | MYGN | Myriad Genetics, Inc. | 538.35M | 0.71% | 679,240 | 829.00M |
| 456 | CTNM | Contineum Therapeutics, Inc. | 537.24M | -2.44% | 136,474 | - |
| 457 | PRME | Prime Medicine, Inc. | 536.43M | -3.88% | 2,485,803 | 4.03M |
| 458 | ANL | Adlai Nortye Ltd. | 528.80M | -0.30% | 145,029 | 5.00M |
| 459 | ARVN | Arvinas, Inc. | 523.91M | -1.69% | 704,977 | 89.40M |
| 460 | EVH | Evolent Health, Inc. | 521.91M | -16.70% | 11,186,765 | 1.89B |
| 461 | EIKN | Eikon Therapeutics, Inc. | 520.81M | 0.10% | 242,336 | - |
| 462 | DNA | Ginkgo Bioworks Holdings, Inc. | 518.02M | 1.28% | 763,256 | 151.40M |
| 463 | SLBT | SL Science Holding Limited | 512.35M | -5.23% | 142,048 | 3.36M |
| 464 | SOPH | SOPHiA GENETICS SA | 507.57M | -5.47% | 392,033 | 81.18M |
| 465 | TOI | The Oncology Institute, Inc. | 506.91M | -4.16% | 1,339,891 | 545.76M |
| 466 | MCTA | Charming Medical Limited | 504.26M | -0.85% | 4,251,392 | 5.42M |
| 467 | ZURA | Zura Bio Limited | 502.54M | -2.04% | 427,509 | - |
| 468 | NPCE | NeuroPace, Inc. | 500.50M | 0.69% | 553,283 | 99.53M |
| 469 | ASMB | Assembly Biosciences, Inc. | 499.79M | -3.15% | 191,256 | 71.10M |
| 470 | ARTV | Artiva Biotherapeutics, Inc. | 492.20M | 1.10% | 255,407 | 251.00K |
| 471 | KIDS | OrthoPediatrics Corp. | 480.82M | -2.80% | 147,895 | 243.30M |
| 472 | HELP | Cybin Inc. | 479.14M | -1.15% | 990,485 | - |
| 473 | TLRY | Tilray Brands, Inc. | 475.94M | -4.09% | 4,045,320 | 858.28M |
| 474 | WEAV | Weave Communications, Inc. | 474.21M | -2.93% | 890,562 | 248.72M |
| 475 | AQST | Aquestive Therapeutics, Inc. | 473.01M | -4.31% | 2,015,861 | 50.27M |
| 476 | NRC | NRC Health | 469.44M | -3.52% | 88,545 | 138.64M |
| 477 | PROK | ProKidney Corp. | 459.13M | -0.65% | 791,711 | 889.00K |
| 478 | VREX | Varex Imaging Corporation | 451.81M | 0.56% | 471,777 | 857.50M |
| 479 | VALN | Valneva SE | 449.16M | -2.45% | 10,689 | 180.25M |
| 480 | OVID | Ovid Therapeutics Inc. | 447.94M | 0.84% | 4,728,431 | 7.12M |
| 481 | VMD | Viemed Healthcare, Inc. | 447.39M | -2.10% | 352,384 | 286.57M |
| 482 | PRTA | Prothena Corporation plc | 446.57M | 1.07% | 532,213 | 57.94M |
| 483 | CABA | Cabaletta Bio, Inc. | 443.51M | -1.09% | 2,307,679 | - |
| 484 | KYTX | Kyverna Therapeutics, Inc. | 443.20M | -1.49% | 648,519 | - |
| 485 | OFIX | Orthofix Medical Inc. | 443.02M | -0.54% | 181,373 | 825.37M |
| 486 | SRTA | Strata Critical Medical, Inc. | 440.42M | 0.20% | 671,739 | 228.58M |
| 487 | PACB | Pacific Biosciences of California, Inc. | 434.84M | 1.45% | 6,861,413 | 160.03M |
| 488 | CLPT | ClearPoint Neuro, Inc. | 434.55M | -3.59% | 785,344 | 40.61M |
| 489 | SGMT | Sagimet Biosciences Inc. | 432.88M | -0.57% | 619,393 | - |
| 490 | OCGN | Ocugen, Inc. | 429.92M | -1.55% | 3,295,851 | 4.47M |
| 491 | DCTH | Delcath Systems, Inc. | 429.10M | -0.80% | 273,564 | 90.44M |
| 492 | NNNN | Anbio Biotechnology | 427.50M | 3.07% | 17,768 | 8.65M |
| 493 | SI | Shoulder Innovations, Inc. | 420.99M | -0.05% | 66,770 | 53.89M |
| 494 | EDIT | Editas Medicine, Inc. | 418.95M | -1.80% | 1,437,251 | 38.69M |
| 495 | LRMR | Larimar Therapeutics, Inc. | 418.58M | -0.25% | 698,871 | - |
| 496 | EPRX | Eupraxia Pharmaceuticals Inc. | 410.72M | -1.87% | 192,668 | - |
| 497 | KMDA | Kamada Ltd. | 410.03M | -0.71% | 27,642 | 181.68M |
| 498 | EVMN | Evommune, Inc. | 407.73M | -0.70% | 827,602 | 10.00M |
| 499 | PBYI | Puma Biotechnology, Inc. | 407.70M | 1.78% | 229,913 | 227.18M |
| 500 | AUTL | Autolus Therapeutics plc | 404.54M | 5.56% | 970,695 | 92.62M |